These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17128801

  • 1. [Adverse neurotoxic reactions of chemotherapy for tuberculosis and their treatment].
    Lysov AV, Mordyk AV, Zatvornitskiĭ VA, Kondria AV.
    Probl Tuberk Bolezn Legk; 2006; (9):45-8. PubMed ID: 17128801
    [Abstract] [Full Text] [Related]

  • 2. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR, Sifakis F, Montes de Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE.
    Arch Intern Med; 2006 Sep 25; 166(17):1863-70. PubMed ID: 17000943
    [Abstract] [Full Text] [Related]

  • 3. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis].
    Panova LV, Ovsiankina ES.
    Probl Tuberk; 2003 Sep 25; (1):28-30. PubMed ID: 12652980
    [Abstract] [Full Text] [Related]

  • 4. [The use of fenazid in patients with pulmonary tuberculosis with poor isoniazid tolerance].
    Borisova MI, Stakhanov VA, Sharkova TI, Ivashchenko NA.
    Probl Tuberk Bolezn Legk; 2003 Sep 25; (7):34-7. PubMed ID: 12939876
    [Abstract] [Full Text] [Related]

  • 5. [The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
    Bal'tseva LB, Mel'nik GV, Man'ko VP.
    Vrach Delo; 1990 Apr 25; (4):71-3. PubMed ID: 2275176
    [Abstract] [Full Text] [Related]

  • 6. [Follow-up of antitubercular treatment].
    Gavira R, Gómez F, Otero MJ, Barrueco M, Domínguez-Gil A.
    Rev Clin Esp; 1994 Sep 25; 194(9):677-81. PubMed ID: 7984795
    [Abstract] [Full Text] [Related]

  • 7. [The prevention of neurotoxic reactions during the treatment of pulmonary tuberculosis in middle-aged and elderly patients].
    Markova EF.
    Vrach Delo; 1990 Oct 25; (10):56-8. PubMed ID: 2080583
    [Abstract] [Full Text] [Related]

  • 8. Isoniazid associated, painful, bilateral gynaecomastia.
    Khanna P, Panjabi C, Maurya V, Shah A.
    Indian J Chest Dis Allied Sci; 2003 Oct 25; 45(4):277-9. PubMed ID: 12962465
    [Abstract] [Full Text] [Related]

  • 9. Isoniazid-induced pellagra.
    Bilgili SG, Karadag AS, Calka O, Altun F.
    Cutan Ocul Toxicol; 2011 Dec 25; 30(4):317-9. PubMed ID: 21517721
    [Abstract] [Full Text] [Related]

  • 10. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents].
    Savula MM, Kravchenko NS, Poznanskiĭ AI.
    Probl Tuberk; 1993 Dec 25; (5):18-20. PubMed ID: 8295877
    [Abstract] [Full Text] [Related]

  • 11. [Rationale for the use of regional lymphotropic therapy in the management of tuberculosis in adolescents].
    Firsova VA, Gubkina MF.
    Probl Tuberk; 1996 Dec 25; (6):47-50. PubMed ID: 9019770
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM, Belotserkovskiĭ VG.
    Probl Tuberk; 1999 Dec 25; (6):14-6. PubMed ID: 10715948
    [Abstract] [Full Text] [Related]

  • 14. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
    Spyridis NP, Spyridis PG, Gelesme A, Sypsa V, Valianatou M, Metsou F, Gourgiotis D, Tsolia MN.
    Clin Infect Dis; 2007 Sep 15; 45(6):715-22. PubMed ID: 17712755
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA, Kaminskaia GO, Kossiĭ IuE, Chernykh NA.
    Probl Tuberk; 2001 Mar 15; (7):26-7. PubMed ID: 11763557
    [Abstract] [Full Text] [Related]

  • 18. Isoniazid induced gynaecomastia: a case report.
    Garg R, Vaibhav, Mehra S, Prasad R.
    Indian J Tuberc; 2009 Jan 15; 56(1):51-4. PubMed ID: 19402273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroimaging findings in isoniazid central nervous system toxicity, presumed intramyelinic edema.
    Hawkes M, Kitai I, Blaser S, Cohen E, Bitnun A, Fluss J, Tran D.
    Eur J Paediatr Neurol; 2008 Nov 15; 12(6):512-5. PubMed ID: 18243740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.